Scopus BioPharma Inc (CE) (SCPS) Actualités

Form 1-Z -

Form 15-12G - Securities registration termination [Section 12(g)]

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Proxy Soliciting Materials (revised) (prer14a)

     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549   SCHEDULE...

Form PRER14A - Preliminary Proxy Soliciting materials

Quarterly Report (10-q)

0001772028--12-312023Q1falseScopus BioPharma Inc.00675000039584264210942640.10001772028us-gaap:RetainedEarningsMember2023-03-310001772028us-gaap:Pa...

Amended Annual Report (10-k/a)

0001772028 false --12-31 2022 FY 0001772028 2022-01-01 2022-12-31...

Annual Report (10-k)

210942641725239100210942642109426400017720282022FYfalse675000000001772028us-gaap:MeasurementInputRiskFreeInteres...